ANTH (Anthera Pharmaceuticals) Cyclically Adjusted PB Ratio: (As of Aug. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Anthera Pharmaceuticals Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Anthera Pharmaceuticals  (OTCPK:ANTH) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Anthera Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms


Anthera Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Anthera Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anthera Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Anthera Pharmaceuticals Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Anthera Pharmaceuticals Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ANTH vs TIKRF, CAPS, AKAOQ: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, Anthera Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anthera Pharmaceuticals Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anthera Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Anthera Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



Anthera Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Anthera Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2018 is calculated as:

For example, Anthera Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2018 was:

Adj_Book=Book Value per Share/CPI of Mar. 2018 (Change)*Current CPI (Mar. 2018)
=0.209/249.5540*249.5540
=0.209

Current CPI (Mar. 2018) = 249.5540.

Anthera Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
200712 -17.418 210.036 -20.695
200809 0.000 218.783 0.000
200812 -1.389 210.228 -1.649
200903 0.000 212.709 0.000
200906 -22.083 215.693 -25.550
200909 -32.501 215.969 -37.555
200912 -36.460 215.949 -42.134
201003 156.475 217.631 179.427
201006 140.310 217.965 160.645
201009 136.885 218.439 156.383
201012 111.614 219.179 127.082
201103 79.679 223.467 88.981
201106 112.090 225.722 123.925
201109 74.590 226.889 82.041
201112 29.819 225.672 32.975
201203 -2.109 229.392 -2.294
201206 -28.854 229.478 -31.378
201209 4.377 231.407 4.720
201212 -2.850 229.601 -3.098
201303 14.333 232.773 15.366
201306 11.551 233.504 12.345
201309 9.513 234.149 10.139
201312 6.081 233.049 6.512
201403 4.223 236.293 4.460
201406 3.695 238.343 3.869
201409 1.557 238.031 1.632
201412 -0.786 234.812 -0.835
201503 7.843 236.119 8.289
201506 5.423 238.638 5.671
201509 9.091 237.945 9.535
201512 7.930 236.525 8.367
201603 6.090 238.132 6.382
201606 3.979 241.018 4.120
201609 1.439 241.428 1.487
201612 0.671 241.432 0.694
201703 0.237 243.801 0.243
201706 0.399 244.955 0.406
201709 0.001 246.819 0.001
201712 -0.421 246.524 -0.426
201803 0.209 249.554 0.209

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Anthera Pharmaceuticals Business Description

Address 700 Milam, Suite 1300, Houston, TX, USA, 77002
Anthera Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. The company currently has one Phase 3-ready clinical program and two Phase 2 clinical programs. It was established in 2004.